Apimeds Pharmaceuticals US, Inc. (APUS) stock
APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
$2.23−0.04 (-1.76%)
Close on Nov 13, 2026Market cap $3.37MP/E –Yield –
Apimeds Pharmaceuticals US enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Apimeds Pharmaceuticals US's enterprise value was $3.28M on Nov 11, 2026, against $29.48M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.28M | -75.9% |
| 2025 | Dec 31, 2025 | $13.64M | – |
See a number that looks wrong?